Caterina Fanello
Overview
Explore the profile of Caterina Fanello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ayuen D, Olupot-Olupot P, Muhindo R, Onyamboko M, Ajayi S, Chimjinda N, et al.
Malar J
. 2025 Mar;
24(1):77.
PMID: 40069748
Background: Anaemia is a deleterious consequence of malaria, and its accurate diagnosis is crucial for effective management. However, laboratory methods for measuring haemoglobin (Hb) concentration, like the Coulter Counter and...
2.
Onyamboko M, Wasakul V, Bakomba S, Kayembe D, Nzambiwishe B, Ekombolo P, et al.
Lancet Glob Health
. 2025 Feb;
13(3):e479-e487.
PMID: 40021306
Background: Genomic surveillance is a valuable tool for detecting changes in the drug susceptibility of malaria parasites, enabling timely adjustments to treatment strategies. However, implementation can be costly and challenging...
3.
Onyamboko M, Olupot-Olupot P, Were W, Namayanja C, Onyas P, Titin H, et al.
BMC Med
. 2023 Oct;
21(1):397.
PMID: 37858129
Background: Single low-dose primaquine (SLDPQ) effectively blocks the transmission of Plasmodium falciparum malaria, but anxiety remains regarding its haemolytic potential in patients with glucose-6-phopshate dehydrogenase (G6PD) deficiency. We, therefore, examined...
4.
Mukaka M, Onyamboko M, Olupot-Olupot P, Peerawaranun P, Suwannasin K, Pagornrat W, et al.
EBioMedicine
. 2023 Sep;
96:104805.
PMID: 37757570
Background: There are no pharmacokinetic data of single low dose primaquine (SLDPQ) as transmission blocking in African children with acute Plasmodium falciparum and glucose-6-phosphate dehydrogenase deficiency (G6PDd). Methods: Primaquine pharmacokinetics...
5.
Fanello C, Lee S, Bancone G, Kayembe D, Ndjowo P, Badjanga B, et al.
Am J Trop Med Hyg
. 2023 Sep;
109(4):965-974.
PMID: 37669757
Neonatal hyperbilirubinemia (NH) is a frequent condition that, if left untreated, can lead to neurological disability and death. We assessed the prevalence of NH and associated neonatal and maternal risk...
6.
Haghiri A, Price D, Fitzpatrick P, Dini S, Rajasekhar M, Fanello C, et al.
Clin Pharmacol Ther
. 2023 Sep;
114(6):1304-1312.
PMID: 37666798
The majority of deaths from malaria are in young African children. Parenteral artesunate (ARS) is the first-line treatment for severe falciparum malaria. Since 2015, the World Health Organization has recommended...
7.
Taylor W, Olupot-Olupot P, Onyamboko M, Peerawaranun P, Weere W, Namayanja C, et al.
Lancet Infect Dis
. 2022 Dec;
23(4):471-483.
PMID: 36462528
Background: WHO recommends gametocytocidal, single low-dose primaquine for blocking the transmission of Plasmodium falciparum; however, safety concerns have hampered the implementation of this strategy in sub-Saharan Africa. We aimed to...
8.
Srinamon K, Watson J, Silamut K, Intharabut B, Phu N, Diep P, et al.
Nat Commun
. 2022 Nov;
13(1):6882.
PMID: 36371433
Severe falciparum malaria is a major cause of death in tropical countries, particularly in African children. Rapid and accurate diagnosis and prognostic assessment are critical to clinical management. In 6027...
9.
Watson J, Warsame M, Peto T, Onyamboko M, Fanello C, Dondorp A, et al.
BMJ Glob Health
. 2022 Jul;
7(7).
PMID: 35831037
No abstract available.
10.
Cutts J, OFlaherty K, Zaloumis S, Ashley E, Chan J, Onyamboko M, et al.
J Infect Dis
. 2022 Jun;
226(2):324-331.
PMID: 35703955
Background: Understanding the effect of immunity on Plasmodium falciparum clearance is essential for interpreting therapeutic efficacy studies designed to monitor emergence of artemisinin drug resistance. In low-transmission areas of Southeast...